Urge Full Hearing Of Legal Claims in STALEY V. GILEAD
FAIR PRICING COALITION URGES FULL HEARING OF LEGAL CLAIMS IN STALEY V. GILEAD WASHINGTON DC, November 11, 2019 – The Fair Pricing Coalition (FPC), a national group advocating for reasonable costs for HIV and hepatitis drugs, today expressed solidarity with the Treatment Action Group, AIDS Action Baltimore, Health GAP, Housing Works, the SERO Project, and amfAR, who have filed an amicus curiae brief in the case of Peter Staley, et al., v. Gilead Sciences, Inc. et al. opposing a motion by Gilead for dismissal. The Staley et al. class action lawsuit, filed in May 2019, charges that Gilead, in allowing its widely used antiretroviral drugs to be compounded with those of other companies into single tablets, prohibited Bristol-Myers Squibb, Janssen Pharmaceuticals, and Japan Tobacco from using less expensive generic components, even after patents expire. These arrangements, plaintiffs assert, are anti-competitive and will maintain excessive prices for HIV/AIDS d...